An in-depth look to SANGAMO THERAP.INC.DL-,01 operating, investing, and financing activities

GBY free cash flow for Q4 24 is -3.38 M EUR. For 2024, GBY free cash flow was -65.11 M EUR and operating cash flow was -64.85 M EUR.